BioCentury | Mar 24, 2003
Finance

Clearing the debris in Germany

...Novosom AG (Halle) and colon cancer play Indivumed GmbH (Hamburg), and acquired the assets of Jomaa Pharmaka GmbH...
...or will acquire the assets itself. As an example, BioAgency last month acquired all of Jomaa's...
...for a second round and also failed to streamline its business model," Björn Lindemann said. Jomaa...
BioCentury | Dec 16, 2002
Clinical News

Fosmidomycin infectious disease data

...hours. The most frequent adverse events were headache, weakness, myalgia, abdominal pain and loose stools. Jomaa Pharmaka GmbH...
Items per page:
1 - 2 of 2
BioCentury | Mar 24, 2003
Finance

Clearing the debris in Germany

...Novosom AG (Halle) and colon cancer play Indivumed GmbH (Hamburg), and acquired the assets of Jomaa Pharmaka GmbH...
...or will acquire the assets itself. As an example, BioAgency last month acquired all of Jomaa's...
...for a second round and also failed to streamline its business model," Björn Lindemann said. Jomaa...
BioCentury | Dec 16, 2002
Clinical News

Fosmidomycin infectious disease data

...hours. The most frequent adverse events were headache, weakness, myalgia, abdominal pain and loose stools. Jomaa Pharmaka GmbH...
Items per page:
1 - 2 of 2